What dose of Dexrazoxane is recommended for patients receiving Doxorubicin?

The recommended dose of Dexrazoxane for patients receiving Doxorubicin is 550 mg/m². Dexrazoxane is utilized primarily to reduce the risk of cardiotoxicity associated with Doxorubicin, which is an anthracycline antibiotic used in cancer treatment. The dosing guidelines for Dexrazoxane indicate that it should be administered as part of a protective regimen to mitigate potential heart damage from Doxorubicin, making this dosage crucial for patient safety and treatment efficacy. The established dosing protocols ensure that the therapeutic benefits of Doxorubicin can be maximized while minimizing adverse effects, specifically the cardiotoxicity that can lead to complications later in therapy.